Morgan Stanley’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115M | Buy |
|
|||||
|
2025
Q1 | $69.1M | Sell |
|
|||||
|
2024
Q4 | $88.3M | Buy |
|
|||||
|
2024
Q3 | $92.2M | Sell |
|
|||||
|
2024
Q2 | $99.5M | Buy |
|
|||||
|
2024
Q1 | $118M | Sell |
|
|||||
|
2023
Q4 | $223M | Buy |
|
|||||
|
2023
Q3 | $103M | Buy |
|
|||||
|
2023
Q2 | $108M | Buy |
|
|||||
|
2023
Q1 | $91.7M | Sell |
|
|||||
|
2022
Q4 | $103M | Buy |
|
|||||
|
2022
Q3 | $55.3M | Sell |
|
|||||
|
2022
Q2 | $71M | Buy |
|
|||||
|
2022
Q1 | $54.8M | Sell |
|
|||||
|
2021
Q4 | $75M | Buy |
|
|||||
|
2021
Q3 | $77.4M | Sell |
|
|||||
|
2021
Q2 | $88.4M | Buy |
|
|||||
|
2021
Q1 | $48.6M | Sell |
|
|||||
|
2020
Q4 | $46.6M | Buy |
|
|||||
|
2020
Q3 | $18.6M | Buy |
|
|||||
|
2020
Q2 | $11.5M | Sell |
|
|||||
|
2020
Q1 | $12.6M | Sell |
|
|||||
|
2019
Q4 | $16.3M | Sell |
|
|||||
|
2019
Q3 | $25M | Buy |
|
|||||
|
2019
Q2 | $25.9M | Buy |
|
|||||
|
2019
Q1 | $20.8M | Sell |
|
|||||
|
2018
Q4 | $16.7M | Sell |
|
|||||
|
2018
Q3 | $25.3M | Buy |
|
|||||
|
2018
Q2 | $6.89M | Sell |
|
|||||
|
2018
Q1 | $13M | Buy |
|
|||||
|
2017
Q4 | $10.4M | Sell |
|
|||||
|
2017
Q3 | $97.2M | Sell |
|
|||||
|
2017
Q2 | $96.6M | Buy |
|
|||||
|
2017
Q1 | $55.6M | Buy |
|
|||||
|
2016
Q4 | $15.6M | Buy |
|
|||||
|
2016
Q3 | $6.24M | Sell |
|
|||||
|
2016
Q2 | $11.7M | Sell |
|
|||||
|
2016
Q1 | $21M | Sell |
|
|||||
|
2015
Q4 | $23.6M | Buy |
|
|||||
|
2015
Q3 | $15.1M | Buy |
|
|||||
|
2015
Q2 | $8.76M | Sell |
|
|||||
|
2015
Q1 | $24.5M | Sell |
|
|||||
|
2014
Q4 | $20.7M | Buy |
|
|||||
|
2014
Q3 | $18.6M | Buy |
|
|||||
|
2014
Q2 | $14.1M | Buy |
|
|||||
|
2014
Q1 | $8.39M | Sell |
|
|||||
|
2013
Q4 | $12.6M | Buy |
|
|||||
|
2013
Q3 | $7.18M | Buy |
|
|||||
|
2013
Q2 | $5.9M | Buy |
|